title: Telomere uncapping in progenitor cells with critical telomere shortening is coupled to S-phase progression in vivo.
abstract: Telomeres protect chromosome ends and serve as a substrate for telomerase, a reverse transcriptase that adds DNA repeats to the telomere terminus. In the absence of telomerase, telomeres progressively shorten, ultimately leading to telomere uncapping, a structural change at the telomere that activates DNA damage responses and leads to ligation of chromosome ends. Telomere uncapping has been implicated in aging and cancer, yet the precise mechanism of uncapping and its relationship to cell cycle remain to be defined. Here, we show that telomeres uncap in an S-phase-dependent manner in gastrointestinal progenitors of TERT(-/-) mice. We develop an in vivo assay that allows a quantitative kinetic assessment of telomere dysfunction-induced apoptosis and its relationship to cell cycle. By exploiting the mathematical relationship between rates of generation and clearance of apoptotic cells, we show that 86.2 +/- 8.8% of apoptotic gastrointestinal cells undergo programmed cell death either late in S-phase or in G2. Apoptosis is primarily triggered via a signaling cascade from newly uncapped telomeres to the tumor suppressor p53, rather than by chromosome fusion-bridge breakage, because mitotic blockade did not alter the rate of newly generated apoptotic bodies. These data support a model in which rapidly dividing progenitor cells within a tissue with short telomeres are vulnerable to telomere uncapping during or shortly after telomere replication.
authors.affiliation: Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
authors.forename: Sripriya
authors.initials: S
authors.lastname: Rajaraman
authors.forename: Jinkuk
authors.initials: J
authors.lastname: Choi
authors.forename: Peggie
authors.initials: P
authors.lastname: Cheung
authors.forename: Veronica
authors.initials: V
authors.lastname: Beaudry
authors.forename: Helen
authors.initials: H
authors.lastname: Moore
authors.forename: Steven E
authors.initials: SE
authors.lastname: Artandi
mesh_terms: D000818:Animals; D017209:Apoptosis; D001973:Bromodeoxyuridine; D003433:Crosses, Genetic; D004249:DNA Damage; D016195:G2 Phase; D020287:In Situ Nick-End Labeling; D007413:Intestinal Mucosa / Q000166:cytology / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D008957:Models, Genetic; D016196:S Phase / Q000502:physiology*; D013234:Stem Cells / Q000166:cytology / Q000502:physiology*; D019098:Telomerase / Q000172:deficiency / Q000235:genetics; D016615:Telomere / Q000648:ultrastructure*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000502:physiology
chemical_list: D016159:Tumor Suppressor Protein p53; D019098:Telomerase; C509187:Tert protein, mouse; D001973:Bromodeoxyuridine